Nu-Med Plus (NUMD) EPS (Basic) (2012 - 2025)

Nu-Med Plus (NUMD) posted EPS (Basic) of -$0.0 for Q4 2025, down 5.45% sequentially from -$0.0 in Q3 2025, and down 19.55% YoY from -$0.0 in Q4 2024.

Nu-Med Plus (NUMD) EPS (Basic) (2012 - 2025) Analysis & Trends

Nu-Med Plus has reported EPS (Basic) for 14 years, with the latest figure at -$0.0 in Q4 2025.

Quarterly EPS (Basic) fell 19.55% year-over-year to -$0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.0 (up 17.8% YoY) and the FY2025 annual result came in at -$0.0, up 17.8% from the prior year.
EPS (Basic) retreated to -$0.0 in Q4 2025 per NUMD's latest filing, from -$0.0 in the prior quarter.
Over five years, EPS (Basic) peaked at $0.0 in Q4 2022 and troughed at -$0.03 in Q4 2021.
A 5-year average of -$0.0 and a median of -$0.0 in 2023 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2022 and 2023: EPS (Basic) jumped 101.79% in 2022, then slumped 230.03% in 2023.
Over 5 years, EPS (Basic) stood at -$0.03 in 2021, then jumped by 101.79% to $0.0 in 2022, then plunged by 230.03% to -$0.0 in 2023, then jumped by 81.77% to -$0.0 in 2024, then slipped by 19.55% to -$0.0 in 2025.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.0, -$0.0, and -$0.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Abbott Laboratories	198.95 Bn	193.34 Bn	7.27 Bn	0.53
2	Stryker	127.40 Bn	123.93 Bn	4.50 Bn	3.33
3	Medtronic	118.77 Bn	109.55 Bn	6.41 Bn	0.98
4	Boston Scientific	73.24 Bn	72.71 Bn	3.85 Bn	0.62
5	Edwards Lifesciences	51.95 Bn	47.70 Bn	1.35 Bn	0.42
6	Dexcom	34.39 Bn	32.44 Bn	830.00 Mn	0.65
7	GE HealthCare Technologies	33.87 Bn	31.76 Bn	2.18 Bn	1.27
8	Koninklijke Philips	26.34 Bn	23.02 Bn	4.55 Bn	0.65
9	Steris	23.04 Bn	22.56 Bn	684.20 Mn	2.06
10	Nu-Med Plus	2.03 Mn	2.02 Mn	-	0.00

Download Data